Synthesis and evaluation of tripeptidyl α-ketoamides as human rhinovirus 3C protease inhibitors

被引:25
作者
Chen, SH [1 ]
Lamar, J
Victor, F
Snyder, N
Johnson, R
Heinz, BA
Wakulchik, M
Wang, QM
机构
[1] Lilly Corp Ctr, Lilly Res Labs, Discovery Chem Res & Technol, Indianapolis, IN 46285 USA
[2] Lilly Corp Ctr, Lilly Res Labs, Dept Infect Dis, Indianapolis, IN 46285 USA
关键词
D O I
10.1016/S0960-894X(03)00753-4
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We describe herein the synthesis and biological evaluation of a series of tripeptidyl alpha-ketoamides as human rhinovirus (HRV) 3C protease inhibitors. The most potent inhibitor discussed in this manuscript, 41, exhibited impressive enzyme inhibitory activity as well as antiviral activity against HRV-14. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3531 / 3536
页数:6
相关论文
共 27 条
  • [1] BABINE R, 2002, Patent No. 0218369
  • [2] NEW METHOD FOR DEOXYGENATION OF SECONDARY ALCOHOLS[J]. BARTON, DHR;MCCOMBIE, SW. JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1975(16)
  • [3] The diisopropylcarbodiimide/1-hydroxy-7-azabenzotriazole system: Segment coupling and stepwise peptide assembly[J]. Carpino, LA;El-Faham, A. TETRAHEDRON, 1999(22)
  • [4] CORDINGLEY MG, 1990, J BIOL CHEM, V265, P9062
  • [5] PYBOP - A NEW PEPTIDE COUPLING REAGENT DEVOID OF TOXIC BY-PRODUCT[J]. COSTE, J;LENGUYEN, D;CASTRO, B. TETRAHEDRON LETTERS, 1990(02)
  • [6] COUCH RB, 1990, VIROLOGY
  • [7] READILY ACCESSIBLE 12-I-5 OXIDANT FOR THE CONVERSION OF PRIMARY AND SECONDARY ALCOHOLS TO ALDEHYDES AND KETONES[J]. DESS, DB;MARTIN, JC. JOURNAL OF ORGANIC CHEMISTRY, 1983(22)
  • [8] Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitors[J]. Dragovich, PS;Zhou, R;Webber, SE;Prins, TJ;Kwok, AK;Okano, K;Fuhrman, SA;Zalman, LS;Maldonado, FC;Brown, EL;Meador, JW;Patick, AK;Ford, CE;Brothers, MA;Binford, SL;Matthews, DA;Ferre, RA;Worland, ST. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000(01)
  • [9] Recent advances in the development of human rhinovirus 3C protease inhibitors[J]. Dragovich, PS. EXPERT OPINION ON THERAPEUTIC PATENTS, 2001(02)
  • [10] Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors.: 4.: Incorporation of P1 lactam moieties as L-glutamine replacements[J]. Dragovich, PS;Prins, TJ;Zhou, R;Webber, SE;Marakovits, JT;Fuhrman, SA;Patick, AK;Matthews, DA;Lee, CA;Ford, CE;Burke, BJ;Rejto, PA;Hendrickson, TF;Tuntland, T;Brown, EL;Meador, JW;Ferre, RA;Harr, JEV;Kosa, MB;Worland, ST. JOURNAL OF MEDICINAL CHEMISTRY, 1999(07)